Pages with the most revisions

Jump to navigation Jump to search

Showing below up to 250 results in range #1 to #250.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

  1. ICRP Glossary‏‎ (267 revisions)
  2. Application of ionising radiation in healthcare‏‎ (98 revisions)
  3. Information for healthcare providers‏‎ (80 revisions)
  4. Information for patients, family members, carers and the public‏‎ (62 revisions)
  5. System Of Radiation Protection Overview‏‎ (43 revisions)
  6. Guide to Radiological Protection in Healthcare‏‎ (43 revisions)
  7. General Information on Radon‏‎ (31 revisions)
  8. Main Page‏‎ (29 revisions)
  9. Application of ionising radiation in healthcare (old)‏‎ (24 revisions)
  10. Information for healthcare providers (old)‏‎ (24 revisions)
  11. Information for patients, family members, carers and the public (old)‏‎ (24 revisions)
  12. Effective dose‏‎ (23 revisions)
  13. Radon For Governments and Employers‏‎ (23 revisions)
  14. Radon For Homeowners and Residents‏‎ (22 revisions)
  15. The System of Radiological Protection‏‎ (21 revisions)
  16. Guide to Radon‏‎ (19 revisions)
  17. Tissue weighting factor‏‎ (17 revisions)
  18. List of ICRP Publications on Radiological Protection in Healthcare‏‎ (16 revisions)
  19. ICRP publications‏‎ (14 revisions)
  20. System of radiation protection module 2‏‎ (14 revisions)
  21. Quotes from Publications on the System of Radiological Protection‏‎ (13 revisions)
  22. Equivalent dose‏‎ (11 revisions)
  23. Absorbed, Equivalent, and Effective Dose‏‎ (10 revisions)
  24. Objectives of Radiological Protection‏‎ (9 revisions)
  25. Air-kerma rate constant‏‎ (9 revisions)
  26. Fundamental Principles of Radiological Protection‏‎ (9 revisions)
  27. Absorbed dose‏‎ (9 revisions)
  28. Effects of Exposure‏‎ (8 revisions)
  29. Prudence‏‎ (8 revisions)
  30. Beneficence‏‎ (8 revisions)
  31. Organ/tissue absorbed dose‏‎ (8 revisions)
  32. Collective effective dose‏‎ (7 revisions)
  33. Linear energy transfer‏‎ (6 revisions)
  34. Accelerated fractionation‏‎ (6 revisions)
  35. Exposure Categories and Situations‏‎ (6 revisions)
  36. Investigation level‏‎ (6 revisions)
  37. Alimentary tract‏‎ (6 revisions)
  38. ICRPædia Guides‏‎ (6 revisions)
  39. Justice‏‎ (6 revisions)
  40. Justification‏‎ (5 revisions)
  41. Kerma‏‎ (5 revisions)
  42. Protection quantities‏‎ (5 revisions)
  43. Types of materials‏‎ (5 revisions)
  44. Radiation weighting factor‏‎ (5 revisions)
  45. Air-kerma, entrance surface‏‎ (5 revisions)
  46. Sources of Radiation Exposure‏‎ (5 revisions)
  47. Dose coefficient‏‎ (5 revisions)
  48. Quality factor‏‎ (5 revisions)
  49. Principle of optimisation‏‎ (5 revisions)
  50. ICRPædia Guide to the System of Radiological Protection‏‎ (5 revisions)
  51. Absorbed fraction‏‎ (5 revisions)
  52. Effective half-life‏‎ (4 revisions)
  53. Averted dose‏‎ (4 revisions)
  54. Kp index‏‎ (4 revisions)
  55. Protective action‏‎ (4 revisions)
  56. Reference Animal and Plant‏‎ (4 revisions)
  57. Source-related assessment‏‎ (4 revisions)
  58. Forbiddenness‏‎ (4 revisions)
  59. Aerodynamic diameter‏‎ (4 revisions)
  60. ICRP‏‎ (4 revisions)
  61. Diagnostic reference level‏‎ (4 revisions)
  62. Risk‏‎ (4 revisions)
  63. Senescence‏‎ (4 revisions)
  64. Reference bioassay function‏‎ (4 revisions)
  65. Air-kerma, product‏‎ (4 revisions)
  66. Fractionation sensitivity‏‎ (4 revisions)
  67. Optimisation‏‎ (4 revisions)
  68. Sievert‏‎ (4 revisions)
  69. Air kerma at the patient entrance reference point‏‎ (4 revisions)
  70. S coefficient (radiation weighted)‏‎ (4 revisions)
  71. Non-maleficence‏‎ (4 revisions)
  72. High linear energy transfer radiation‏‎ (4 revisions)
  73. Direct bioassay‏‎ (4 revisions - redirect page)
  74. Bioassay‏‎ (4 revisions)
  75. Calculating Radon Doses‏‎ (4 revisions)
  76. Computed tomography dose index‏‎ (4 revisions)
  77. Mass median diameter‏‎ (4 revisions)
  78. Alpha decay‏‎ (4 revisions)
  79. Effective charge number‏‎ (4 revisions)
  80. Math‏‎ (4 revisions)
  81. Programmed cell death‏‎ (4 revisions)
  82. Dose equivalent‏‎ (3 revisions)
  83. Field-size effect (Volume effect)‏‎ (3 revisions)
  84. Gastrointestinal syndrome‏‎ (3 revisions)
  85. Wisdom‏‎ (3 revisions)
  86. Biomedical research volunteer‏‎ (3 revisions)
  87. Cardiomyopathy‏‎ (3 revisions)
  88. Dose limit‏‎ (3 revisions)
  89. Target region‏‎ (3 revisions)
  90. Flexible tissues‏‎ (3 revisions)
  91. Guide to the System of Radiological Protection‏‎ (3 revisions)
  92. Autonomy‏‎ (3 revisions)
  93. Dose‏‎ (3 revisions)
  94. Dose limits‏‎ (3 revisions)
  95. Fluence‏‎ (3 revisions)
  96. Constancy test‏‎ (3 revisions)
  97. DS02‏‎ (3 revisions)
  98. Fluoroscopically guided interventions‏‎ (3 revisions)
  99. Annual dose‏‎ (3 revisions)
  100. Potential exposure‏‎ (3 revisions)
  101. Rigidity threshold‏‎ (3 revisions)
  102. Dose of record (E)‏‎ (3 revisions)
  103. Low Earth orbit‏‎ (3 revisions)
  104. Accountability‏‎ (3 revisions)
  105. X ray‏‎ (3 revisions)
  106. Half-life, physical‏‎ (3 revisions)
  107. Cell death‏‎ (3 revisions)
  108. Contamination‏‎ (3 revisions)
  109. Exponential survival curve‏‎ (3 revisions)
  110. Unsealed source‏‎ (3 revisions)
  111. Xerostomia‏‎ (3 revisions)
  112. Annual limit on intake‏‎ (3 revisions)
  113. Dose per content function‏‎ (3 revisions)
  114. Interphase death‏‎ (3 revisions)
  115. Equity‏‎ (3 revisions)
  116. Test‏‎ (3 revisions)
  117. Graded approach‏‎ (3 revisions)
  118. Public exposure‏‎ (3 revisions)
  119. Fractionation‏‎ (3 revisions)
  120. Uptake‏‎ (3 revisions)
  121. Active (red) bone marrow‏‎ (3 revisions)
  122. Utilitarian ethics‏‎ (3 revisions)
  123. Granulocyte-macrophage colony-stimulating factor‏‎ (3 revisions)
  124. Operational quantity‏‎ (3 revisions)
  125. Value judgement‏‎ (3 revisions)
  126. Granulocyte colony-stimulating factor‏‎ (3 revisions)
  127. Coster-Kronig transition‏‎ (3 revisions)
  128. Emergency preparedness‏‎ (3 revisions)
  129. Valvular heart disease‏‎ (3 revisions)
  130. Gray‏‎ (3 revisions)
  131. Personal dose equivalent‏‎ (3 revisions)
  132. Principle of justification‏‎ (3 revisions)
  133. Radiofrequency ablation‏‎ (3 revisions)
  134. Iso-effect plots‏‎ (3 revisions)
  135. Emergency procedures‏‎ (3 revisions)
  136. Lifetime risk estimates‏‎ (3 revisions)
  137. Absolute risk‏‎ (3 revisions)
  138. Virtue ethics‏‎ (3 revisions)
  139. Auger transition‏‎ (3 revisions)
  140. Bystander effect‏‎ (3 revisions)
  141. Derived air concentration‏‎ (3 revisions)
  142. Dignity‏‎ (3 revisions)
  143. Isomers‏‎ (3 revisions)
  144. Employer‏‎ (3 revisions)
  145. Activity median thermodynamic diameter‏‎ (3 revisions)
  146. Voxel phantom‏‎ (3 revisions)
  147. Radiological Protection in Healthcare‏‎ (3 revisions - redirect page)
  148. Complex tissues‏‎ (3 revisions)
  149. Growth fraction‏‎ (3 revisions)
  150. Organ dose equivalent‏‎ (3 revisions)
  151. Excretion rate (instantaneous)‏‎ (3 revisions)
  152. Extrathoracic airways‏‎ (3 revisions)
  153. Galactic cosmic radiation‏‎ (3 revisions)
  154. Growth hormone (somatotropin)‏‎ (3 revisions)
  155. ICRP Publication 103‏‎ (3 revisions)
  156. Spread-out Bragg peak‏‎ (3 revisions)
  157. Fairness‏‎ (3 revisions)
  158. Absorption‏‎ (3 revisions)
  159. Gamma ray‏‎ (3 revisions)
  160. Recovery‏‎ (3 revisions)
  161. DNA damage signalling‏‎ (3 revisions)
  162. Retrievability‏‎ (2 revisions)
  163. Immune system‏‎ (2 revisions)
  164. Institutional control‏‎ (2 revisions)
  165. Stakeholder‏‎ (2 revisions)
  166. Environmental radiation protection‏‎ (2 revisions)
  167. Tachycardia‏‎ (2 revisions)
  168. Exemption level‏‎ (2 revisions)
  169. Tissue equivalent material‏‎ (2 revisions)
  170. Myocardial stress test‏‎ (2 revisions)
  171. Oversight‏‎ (2 revisions)
  172. Projected dose‏‎ (2 revisions)
  173. Co-expertise‏‎ (2 revisions)
  174. Radionuclides of natural origin‏‎ (2 revisions)
  175. Connective tissue‏‎ (2 revisions)
  176. Recovery (cellular or tissue)‏‎ (2 revisions)
  177. DRL process‏‎ (2 revisions)
  178. Reversibility‏‎ (2 revisions)
  179. In vivo radiobioassay‏‎ (2 revisions)
  180. Solar particle event‏‎ (2 revisions)
  181. Effective dose equivalent‏‎ (2 revisions)
  182. Existing exposure situation‏‎ (2 revisions)
  183. Gastroschisis‏‎ (2 revisions)
  184. Worker‏‎ (2 revisions)
  185. Nuclear track detectors‏‎ (2 revisions)
  186. Angiogenesis‏‎ (2 revisions)
  187. Hyperbaric oxygen‏‎ (2 revisions)
  188. Bioturbation‏‎ (2 revisions)
  189. Cardioverter-defibrillator‏‎ (2 revisions)
  190. Radiation safety officer‏‎ (2 revisions)
  191. Radioresponsiveness‏‎ (2 revisions)
  192. Consequential late effects‏‎ (2 revisions)
  193. Recovery responder‏‎ (2 revisions)
  194. Rehabilitation of living conditions‏‎ (2 revisions)
  195. Right to know‏‎ (2 revisions)
  196. Incidence‏‎ (2 revisions)
  197. Solar wind‏‎ (2 revisions)
  198. Epithelium‏‎ (2 revisions)
  199. Target tissue‏‎ (2 revisions)
  200. Measuring and Reducing Radon Levels in your Home‏‎ (2 revisions)
  201. Acceptance test‏‎ (2 revisions)
  202. Gastrulation‏‎ (2 revisions)
  203. Working level‏‎ (2 revisions)
  204. OLINDA/EXM‏‎ (2 revisions)
  205. Habitual mouth breather‏‎ (2 revisions)
  206. Annihilation photons‏‎ (2 revisions)
  207. Particle radiance‏‎ (2 revisions)
  208. Hyperfractionation‏‎ (2 revisions)
  209. Bone marrow‏‎ (2 revisions)
  210. Protection strategy‏‎ (2 revisions)
  211. Radiation source‏‎ (2 revisions)
  212. Cohort study‏‎ (2 revisions)
  213. Radiosensitiser‏‎ (2 revisions)
  214. DRL value‏‎ (2 revisions)
  215. Rigidity‏‎ (2 revisions)
  216. Dose-length product‏‎ (2 revisions)
  217. Security‏‎ (2 revisions)
  218. Incident‏‎ (2 revisions)
  219. Intermediate level waste‏‎ (2 revisions)
  220. Stenosis‏‎ (2 revisions)
  221. Equieffective dose‏‎ (2 revisions)
  222. Local DRL‏‎ (2 revisions)
  223. Expanded and aligned radiation field‏‎ (2 revisions)
  224. Tolerability‏‎ (2 revisions)
  225. Medical exposure‏‎ (2 revisions)
  226. Naturally occurring radioactive material‏‎ (2 revisions)
  227. Adventitious‏‎ (2 revisions)
  228. Working level month‏‎ (2 revisions)
  229. Habitual nose breather‏‎ (2 revisions)
  230. Hypertrophic cardiomyopathy‏‎ (2 revisions)
  231. Background dose (rate)‏‎ (2 revisions)
  232. Radiosensitivity, cellular‏‎ (2 revisions)
  233. Containment‏‎ (2 revisions)
  234. Detriment‏‎ (2 revisions)
  235. Dose-rate effect‏‎ (2 revisions)
  236. Inclusiveness‏‎ (2 revisions)
  237. Source-related‏‎ (2 revisions)
  238. Internal conversion electron‏‎ (2 revisions)
  239. Electron-capture decay‏‎ (2 revisions)
  240. LD 50/30‏‎ (2 revisions)
  241. Telangiectasia‏‎ (2 revisions)
  242. Member of the public‏‎ (2 revisions)
  243. Fluoroscopically or computed tomography guided interventions‏‎ (2 revisions)
  244. Unattached fraction‏‎ (2 revisions)
  245. Necrosis‏‎ (2 revisions)
  246. Patient entrance reference point‏‎ (2 revisions)
  247. Hypoplasia‏‎ (2 revisions)
  248. Backscatter detection system‏‎ (2 revisions)
  249. Potential recoverability correction factor‏‎ (2 revisions)
  250. Bradycardia‏‎ (2 revisions)

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)